Tokyo, April 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061139) titled 'Long-term metabolic profiles and treatment intensity during imeglimin therapy in patients with type 2 diabetes: a retrospective observational study' on April 6.
Study Type:
Observational
Primary Sponsor:
Institute - Osaka General Medical Center
Condition:
Condition - type 2 diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To describe long-term changes in glycemic control and endogenous insulin secretion in patients with type 2 diabetes receiving imeglimin in routine clinical practice.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 20
y...